Massachusetts Wealth Management Sells 500 Shares of Colgate-Palmolive (NYSE:CL)

Massachusetts Wealth Management decreased its position in Colgate-Palmolive (NYSE:CL) by 3.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,847 shares of the company’s stock after selling 500 shares during the quarter. Massachusetts Wealth Management’s holdings in Colgate-Palmolive were worth $1,168,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Czech National Bank grew its position in Colgate-Palmolive by 6.5% during the third quarter. Czech National Bank now owns 166,449 shares of the company’s stock valued at $17,279,000 after buying an additional 10,106 shares during the period. Park Avenue Securities LLC grew its position in shares of Colgate-Palmolive by 38.3% during the 3rd quarter. Park Avenue Securities LLC now owns 10,705 shares of the company’s stock valued at $1,111,000 after acquiring an additional 2,966 shares during the period. GAMMA Investing LLC increased its stake in shares of Colgate-Palmolive by 32.4% in the 3rd quarter. GAMMA Investing LLC now owns 10,952 shares of the company’s stock worth $1,137,000 after purchasing an additional 2,677 shares in the last quarter. Miracle Mile Advisors LLC raised its holdings in Colgate-Palmolive by 19.8% in the 3rd quarter. Miracle Mile Advisors LLC now owns 3,842 shares of the company’s stock worth $399,000 after purchasing an additional 636 shares during the period. Finally, Exeter Financial LLC lifted its position in Colgate-Palmolive by 1.1% during the third quarter. Exeter Financial LLC now owns 13,507 shares of the company’s stock valued at $1,402,000 after purchasing an additional 147 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on CL shares. Morgan Stanley decreased their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday. Raymond James reaffirmed an “outperform” rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday. Barclays reduced their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Royal Bank of Canada restated a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Finally, JPMorgan Chase & Co. decreased their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a report on Monday. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Hold” and an average target price of $101.16.

Colgate-Palmolive Trading Down 0.5 %

CL stock opened at $86.56 on Wednesday. The firm’s fifty day simple moving average is $90.98 and its two-hundred day simple moving average is $96.99. The stock has a market capitalization of $70.72 billion, a price-to-earnings ratio of 24.59, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a twelve month low of $82.68 and a twelve month high of $109.30.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the company earned $0.87 earnings per share. As a group, analysts anticipate that Colgate-Palmolive will post 3.74 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.31%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is presently 56.82%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.